Le Registre des lobbyistes
Nombre total de rapports de communication : 0
Rapports mensuels de communications au cours des 6 derniers mois : 0
| Objets | Détails | Catégories |
|---|---|---|
|
Sciences et technologies
|
BioVectra received funding in year to support the expansion of existing technologies in biomanufacturing and mRNA/pDNA vaccine production totaling $22.8M. The total commitment of the funding awarded from the Strategic Innovation Fund (SIF) relating to this project spanning 2022-2024 was $46.5M, the residual amount is expected to be disbursed in fiscal year 2024. This funding agreement was in the form of grant and non-interest bearing repayable loan. BioVectra also sought and secured funding from provincial government in PEI to support capital investment, labor cost and other operational costs associated with the biomanufacturing and mRNA/pDNA production. Those funding agreements came in the form of non-repayable grants totaling $10M and tax incentives, of which $3.3M was received during 2023 fiscal year and the residual is expected over years 2024-2030.
|
Subvention, Contribution ou autre avantage financier
|
BioVectra is a contract development and manufacturing organization (CDMO) that serves pharmaceutical and biotech companies with full-service Current Good Manufacturing Practice (cGMP) outsourcing solutions for intermediates and active pharmaceutical ingredients (APIs).
Oliver Technow, Chief Executive Officer
Date de la fin du dernier exercice financier complet : 2023-12-31
| Institution gouvernementale | Financement reçu au cours du dernier exercice financier | Financement attendu pendant l'exercice financier en cours |
|---|---|---|
| BioTalent | 165 867,75 $ | Oui |
| Innovation PEI | 3 254 327,69 $ | Oui |
| Labor Market Development Program -Skills PEI | 11 714,50 $ | Oui |
| Strategic Innovation Fund | 19 561 585,89 $ | Oui |
Adresse :
11 Aviation Avenue
Charlottetown, PE C1E 0A1
Canada
Numéro de téléphone :
902-566-9116
Numéro de fax :
902-628-2045
BioVectra Inc. ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement